• Corpus ID: 195816735

miR 551 b Regulates Colorectal Cancer Progression by Targeting the ZEB 1 Signaling Axis

@inproceedings{Kim2019miR5B,
  title={miR 551 b Regulates Colorectal Cancer Progression by Targeting the ZEB 1 Signaling Axis},
  author={Kwang Seock Kim and Dongjun Jeong and Ita Novita Sari and Yoseph Toni Wijaya and Nayoung Jun and Sanghyun Lee and Ying-Gui Yang and Sae Hwan Lee and Hyog Young Kwon},
  year={2019}
}
Our current understanding of the role of microRNA 551b (miR551b) in the progression of colorectal cancer (CRC) remains limited. Here, studies using both ectopic expression of miR551b and miR551b mimics revealed that miR551b exerts a tumor suppressive effect in CRC cells. Specifically, miR551b was significantly downregulated in both patient-derived CRC tissues and CRC cell lines compared to normal tissues and non-cancer cell lines. Also, miR551b significantly inhibited the motility of CRC cells… 
1 Citations

Figures from this paper

Prognostic Risk Model of Colorectal Cancer Constructed by Bioinformatics Method and Functional Study of The Gene CLCA1 & SPINK4
TLDR
It is found that CLCA1 and SPINK4 are closely related to survival prognosis, which will enable patients with CRC to be more accurately managed in trials testing new drugs and in clinical practice.

References

SHOWING 1-10 OF 33 REFERENCES
miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression
TLDR
Data indicate that miR-551b inhibits EMT and metastasis in GC by inhibiting ERBB4, which is potential therapeutic targets for the treatment of GC.
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis
Objective Distant metastasis is the major cause of cancer-related death in patients with colorectal cancer (CRC). Although the microRNA-200 (miR-200) family is a crucial inhibitor of
Tumor suppressor miR-128-3p inhibits metastasis and epithelial–mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer
TLDR
It is concluded that miR-128-3p suppresses EMT and metastasis via ZEB1, and miR+3p may be a critical mediator in ESCC.
miR-1199-5p and Zeb1 function in a double-negative feedback loop potentially coordinating EMT and tumour metastasis
TLDR
Using microRNA sequencing in a time-resolved manner and functional validation, the authors uncover a double feedback loop between miR-1199-5p and the Zeb1, potentially coordinating a protein involved in epithelial mesenchymal transition and tumour metastasis.
ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance
TLDR
It is proposed that it is specific EMT inducers like ZEB1, but not the epithelial or mesenchymal state itself, that dictate cancer stem cell properties.
MicroRNAs in the pathogenesis of cancer.
TLDR
The findings reveal a potential and appealing role for miRs as cancer therapeutic targets and aims at providing the molecular bases for the understanding of the potential role of miRs in the translational and clinical setting.
Interferon‐induced transmembrane protein 1‐mediated EGFR/SOX2 signaling axis is essential for progression of non‐small cell lung cancer
TLDR
It is demonstrated that a high level of IFITM1 expression is associated with a poor overall survival (OS) rate in adenocarcinoma but not in squamous cell carcinoma, and it is suggested that IFITm1 is a poor prognostic marker of adenOCarcinomas and an attractive target to develop novel therapeutics for NSCLC.
A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer.
TLDR
A transient BM loss at the invasive front is correlated with increased distant metastasis and poor patient survival, indicating its tumor biologic relevance and usefulness as a prognostic marker.
ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1
TLDR
ZEB1/BRG1 is identified as a new transcriptional mechanism regulating E-cadherin expression and epithelial-to-mesenchymal transdifferentiation that may be involved during the initial stages of tumor invasion.
...
...